Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
14.10
Ask:
16.90
Spread: 2.80 (19.858%)
Market Cap: £12.51m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

First Quarter 2023 Update

28 Apr 2023 07:00

RNS Number : 8455X
LMS Capital PLC
28 April 2023
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28 April 2023

 

 

LMS CAPITAL PLC

First Quarter 2023 Update

 

 

LMS Capital plc (the "Company"), the listed Investment Company, provides the following update covering the three months ended 31 March 2023.

 

Financial Highlights

 

· Unaudited Net Asset Value ("NAV") at 31 March 2023 was £46.1 million (57.2p per share). This compares to £46.5 million (57.7p per share) at 31 December 2022;

· Overall portfolio net gains were £0.1 million. These comprise net underlying gains of £0.5 million (including accrued interest on Dacian) offset by unrealised foreign exchange losses of £0.4 million reflecting the weakening of the US Dollar compared to sterling in Q1; and

· Cash at 31 March 2023 was £17.5 million compared to £17.9 million at 31 December 2022.

 

Unaudited Net Asset Value at 31 March 2023

 

The 31 March 2023 NAV is summarised below:

 

Unaudited

Audited

31 March

2023

31 December

 2022

£ 000s

Mature Investment Portfolio

Quoted Investments

144

160

Unquoted Investments

6,701

6,626

Funds

13,526

14,033

20,371

20,819

New Investment Portfolio

Dacian

10,280

10,145

10,280

10,145

Total Investments

30,651

30,964

Cash

17,490

17,906

Other Net Assets/Liabilities 

(1,995)

(2,329)

Net Asset Value

46,146

46,541

 

The NAV at the end of March is based on the valuation of the Company's investments as at 31 December 2022, adjusted for transactions in the three months ended 31 March 2023, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, and the latest information available from third party fund managers.

 

The £0.4 million decrease in NAV during the first quarter is comprised of the following:

· Net underlying gains of £0.5 million on the investment portfolio;

· £0.4 million of portfolio unrealised foreign exchange losses from the strengthening of sterling against the U.S. Dollar;

· £0.1 million of non-portfolio unrealised foreign exchange losses;

· £0.5 million of running costs and £0.1 million of investment related costs; and

· £0.2 million on bank interest and other income receivable.

 

Portfolio Net Underlying Gains - £0.5 million

 

Quoted Investments

 

The Company's quoted investment valuations remained flat during the first quarter.

 

Unquoted Investments

 

The Company's unquoted investments include our direct holdings in Dacian Petroleum, Medhost, Elateral and a convertible debt instrument with IDE Group Holdings. ICU Eyewear, the final asset managed by San Francisco Equity Partners was disposed of during the period resulting in a realised gain of £0.1 million.

 

Unrealised gains on the unquoted portfolio were £0.4 million during the first quarter all resulting from Medhost.

 

Dacian Petroleum had £0.3 million in investment accrued interest income during the first quarter.

 

Funds

 

The Company's fund investments include its holding in Brockton Capital Fund I, Opus Capital Venture Partners, Weber Capital Partners and five other smaller fund interests.

 

Fund unrealised net losses were £0.3 million. The principal movements were:

· Opus Capital Venture Partners - Unrealised loss of £0.8 million, driven by a reduction in the fund manager's valuation of the Fund's two principal remaining investments, primarily reflecting movements in comparable market indices;

· Brockton Capital Fund 1 - Unrealised gain of £0.3 million, reflecting the unwinding of the discount rate as the investment is valued on a discounted cash flow basis;

· Weber Capital Partners - Unrealised gain of £0.1 million due to the performance in the U.S. microcap equities held in the fund; and

· Other unrealised gains on funds of £0.1 million.

 

The carrying value of the funds is based on the latest available information from the respective fund managers, generally the 31 December 2022 fund valuation reports except for Weber Capital Partners, which is based on 31 March 2023 valuations.

 

Liquidity and Outlook

 

Portfolio realisations were £0.3 million during the period.

 

Cash balances were £17.5 million at 31 March 2023.

 

As laid out in our Annual Report, our 2023 priorities are:

· to bring to fruition the work that has been undertaken, particularly with our real estate teams, to deploy new capital from our own balance sheet in conjunction with our co-investors;

· to support the Dacian team as it enters its second year of operation with an emphasis on its workover program to increase production; and

· to continue to manage the mature asset portfolio to optimise realisation proceeds

 

 

 

For further information please contact:

LMS Capital plc

Nick Friedlos, Managing Director

0207 935 3555

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFIPMITMTATMTJ
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.